UNSPSC 51282120: Azidocillin potassium

This classification denotes a penicillin antibiotic C16H16N5O4S.K, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7932098147, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((azidophenylacetyl)amino)-3,3-dimethyl-7-oxo-, monopotassium salt, (2s-(2.alpha.,5.alpha.,6.beta.(s*)))-, but more generally known as azidocillin potassium, which bears US NIH Compound Identifier 71587048.

UNSPSC 51282120 Azidocillin potassium is a Commodity code, but the recent state and local opportunities tagged under it show minimal direct procurement activity for this specific antibiotic pharmaceutical. Instead, the tagged solicitations center on naloxone and drug deactivation systems, generic multi-source pharmaceuticals through cooperative purchasing, medical and first aid supplies for emergency response, and direct-to-manufacturer prescription programs—none of which align with azidocillin potassium as a standalone line item. State and local health departments, counties, and cooperative purchasing alliances do buy pharmaceuticals through established supply chains, but the code shows little evidence of discrete procurements for azidocillin potassium specifically. The recent activity reflects broader patterns in state and local pharmaceutical acquisition: health systems source generic drugs and OTC products through wholesaler-authorized channels, emergency responders bundle medications with first aid supplies in single solicitations, and some states are exploring direct-to-manufacturer relationships to improve cost management and fulfillment efficiency.

The geographic spread of recent activity includes Florida (Seminole County), Texas (HHS Commission), and Minnesota (MMCAP, serving multiple states including Oregon), though the activities themselves diverge sharply from the code's nominal scope. Seminole County issued an IFB on June 30, 2026, for naloxone and drug deactivation systems with a July 26, 2023 response date; the City of Tampa posted an ITB on March 25, 2026, for medical and first aid supplies (estimated $700,000) with a March 13, 2026 deadline and a Small Local Business Enterprise set-aside; the Texas HHS Commission posted an RFI on April 3, 2026, on direct-to-manufacturer prescription programs; and MMCAP issued an RFP on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline. The code as tagged appears to be a mismatch with actual state and local procurement activity—azidocillin potassium does not surface as a discrete commodity in recent solicitations.